Obi Shuntaro

Researcher Information

Affiliation

Teikyo University Chiba Medical Center Professor
Third Department of Internal Medicine Professor

URL

https://jglobal.jst.go.jp/detail?JGLOBAL_ID=201801020247813755

J-Global ID

• 201801020247813755

Research Interests

• 地域医療   医学教育   炎症性腸疾患   肝炎   Hepatocellular carcinoma   

Research Areas

• Life sciences / Gastroenterology

Education

• 1985/04 - 1991/03  Teikyo University  School of Medicine

Association Memberships

• 日本癌治療学会   日本肝臓学会   日本消化器病学会   日本内科学会   

Research Activity Information

Published Papers

• 肝細胞癌に対するアテゾリズマブ・ベバシズマブ併用療法の現状 多施設共同研究

  竹内 研人; 松本 光太郎; 高橋 健太郎; 徳冨 遥; 高村 尚樹; 田村 大和; 松本 康佑; 三浦 亮; 佐藤 隆久; 淺岡 良成; 佐藤 新平; 菊池 健太郎; 小尾 俊太郎; 田中 篤

  日本消化器病学会雑誌 (一財)日本消化器病学会 119 (臨増大会) A741 - A741 0446-6586 2022/10
• Clinical Practice Guidelines for Hepatic Arterial Infusion Chemotherapy with a Port System Proposed by the Japanese Society of Interventional Radiology and Japanese Society of Implantable Port Assisted Treatment.

  Kazuomi Ueshima; Atsushi Komemushi; Takeshi Aramaki; Hideki Iwamoto; Shuntaro Obi; Yozo Sato; Toshihiro Tanaka; Kiyoshi Matsueda; Michihisa Moriguchi; Hiroya Saito; Miyuki Sone; Takuji Yamagami; Yoshitaka Inaba; Masatoshi Kudo; Yasuaki Arai

  Liver cancer 11 (5) 407 - 425 2022/09
• The Use of Electronic Medical Records-Based Big-Data Informatics to Describe ALT Elevations Higher than 1000 IU/L in Patients with or without Hepatitis B Virus Infection.

  Hiroyuki Amano; Tatsuo Kanda; Hitoshi Mochizuki; Yuichiro Kojima; Yoji Suzuki; Kenji Hosoda; Hiroshi Ashizawa; Yuko Miura; Shotaro Tsunoda; Yosuke Hirotsu; Hiroshi Ohyama; Naoya Kato; Mitsuhiko Moriyama; Shuntaro Obi; Masao Omata

  Viruses 13 (11) 2021/11
• 吐血を契機に診断された食道粘膜類天疱瘡の1例

  原田 文人; 阿部 浩一郎; 高橋 健太郎; 小田 実; 田村 大和; 柳澤 大輔; 大和 洸; 丸山 喬平; 青柳 仁; 磯野 朱里; 三浦 亮; 佐藤 隆久; 有住 俊彦; 相磯 光彦; 小田島 慎也; 淺岡 良成; 山崎 一人; 山本 貴嗣; 小尾 俊太郎; 田中 篤

  日本消化器病学会関東支部例会プログラム・抄録集 日本消化器病学会-関東支部 365回 26 - 26 2021/07
• Hepatic Arterial Infusion Chemotherapy versus Sorafenib in Patients with Advanced Hepatocellular Carcinoma

  Kazuomi Ueshima; Sadahisa Ogasawara; Masafumi Ikeda; Yutaka Yasui; Takeshi Terashima; Tatsuya Yamashita; Shuntaro Obi; Shinpei Sato; Hiroshi Aikata; Takumi Ohmura; Hidekatsu Kuroda; Takamasa Ohki; Kengo Nagashima; Yoshihiko Ooka; Masahiro Takita; Masayuki Kurosaki; Kazuaki Chayama; Shuichi Kaneko; Namiki Izumi; Naoya Kato; Masatoshi Kudo; Masao Omata

  Liver Cancer S. Karger AG 9 (5) 1 - 13 2235-1795 2020/07 [Refereed]
  
• Impact of Adverse Events on the Progression-Free Survival of Patients with Advanced Hepatocellular Carcinoma Treated with Lenvatinib: A Multicenter Retrospective Study.

  Takamasa Ohki; Koki Sato; Mayuko Kondo; Eriko Goto; Takahisa Sato; Yuji Kondo; Masatoshi Akamatsu; Shinpei Sato; Hideo Yoshida; Yukihiro Koike; Shuntaro Obi

  Drugs - real world outcomes 7 (2) 141 - 149 2020/06 [Refereed]
  
• Clinical Features and Liver Injury in Patients with COVID-19 in the Japanese Population.

  Koichiro Abe; Takatsugu Yamamoto; Kotaro Matsumoto; Kentaro Kikuchi; Ryo Miura; Naoko Tachizawa; Yoshinari Asaoka; Tomoko Takezawa; Naohisa Matsunaga; Shuntaro Obi; Atsushi Tanaka

  Internal medicine (Tokyo, Japan) 59 (19) 2353 - 2358 2020
• Objective Response by mRECIST Is an Independent Prognostic Factor for Overall Survival in Hepatocellular Carcinoma Treated with Sorafenib in the SILIUS Trial.

  Masatoshi Kudo; Kazuomi Ueshima; Yasutaka Chiba; Sadahisa Ogasawara; Shuntaro Obi; Namiki Izumi; Hiroshi Aikata; Hiroaki Nagano; Etsuro Hatano; Yutaka Sasaki; Keisuke Hino; Takashi Kumada; Kazuhide Yamamoto; Yasuharu Imai; Shouta Iwadou; Chikara Ogawa; Takuji Okusaka; Fumihiko Kanai; Yasuaki Arai

  Liver cancer 8 (6) 505 - 519 2019/11 [Refereed]
  
• The efficacy and safety of lenvatinib for advanced hepatocellular carcinoma in a real-world setting.

  Shuntaro Obi; Takahisa Sato; Shinpei Sato; Miho Kanda; Yuta Tokudome; Yuichiro Kojima; Yoji Suzuki; Kenji Hosoda; Toshihiro Kawai; Yuji Kondo; Yoshihiro Isomura; Hiroshi Ohyama; Keiko Nakagomi; Hiroshi Ashizawa; Yuko Miura; Hiroyuki Amano; Hitoshi Mochizuki; Masao Omata

  Hepatology international 13 (2) 199 - 204 2019/03 [Refereed]
  
• Prediction of the very early occurrence of HCC right after DAA therapy for HCV infection.

  Yoshihiko Ooka; Kanda Miho; Obi Shuntaro; Masato Nakamura; Sadahisa Ogasawara; Eiichiro Suzuki; Shin Yasui; Tetsuhiro Chiba; Makoto Arai; Tatsuo Kanda; Hitoshi Maruyama; Osamu Yokosuka; Naoya Kato; Hitoshi Mochizuki; Masao Omata

  Hepatology international 12 (6) 523 - 530 2018/11 [Refereed]
  
• [Successful Hepatic Arterial Injection Chemotherapy for Hepatocellular Carcinoma with Inferior Vena Cava Invasion and Extrahepatic Spread in a Patient with Child-Pugh Class BLiver Cirrhosis].

  Yusuke Kajiyama; Kentaro Kikuchi; Shuntaro Obi; Hiroshi Miyakawa; Shinpei Sato; Ichiro Yasuda

  Gan to kagaku ryoho. Cancer & chemotherapy 45 (9) 1339 - 1341 0385-0684 2018/09 [Refereed]
  
• Multicenter, randomized, controlled trial of S-1 monotherapy versus S-1 and interferon-α combination therapy for hepatocellular carcinoma with extrahepatic metastases.

  Hiroaki Nagano; Shuntaro Obi; Etsuro Hatano; Shuichi Kaneko; Fumihiko Kanai; Masao Omata; Akihito Tsuji; Toshiyuki Itamoto; Kazuhide Yamamoto; Masatoshi Tanaka; Shoji Kubo; Koichi Hirata; Hideji Nakamura; Yoshito Tomimaru; Takeharu Yamanaka; Shinsuke Kojima; Morito Monden

  Hepatology research : the official journal of the Japan Society of Hepatology 48 (9) 717 - 726 2018/08 [Refereed]
  
• Sorafenib plus low-dose cisplatin and fluorouracil hepatic arterial infusion chemotherapy versus sorafenib alone in patients with advanced hepatocellular carcinoma (SILIUS): a randomised, open label, phase 3 trial.

  Masatoshi Kudo; Kazuomi Ueshima; Osamu Yokosuka; Sadahisa Ogasawara; Shuntaro Obi; Namiki Izumi; Hiroshi Aikata; Hiroaki Nagano; Etsuro Hatano; Yutaka Sasaki; Keisuke Hino; Takashi Kumada; Kazuhide Yamamoto; Yasuharu Imai; Shouta Iwadou; Chikara Ogawa; Takuji Okusaka; Fumihiko Kanai; Kohei Akazawa; Ken-Ichi Yoshimura; Philip Johnson; Yasuaki Arai

  The lancet. Gastroenterology & hepatology 3 (6) 424 - 432 2018/06 [Refereed]
  
• Regional Differences in Efficacy, Safety, and Biomarkers for Second-Line Axitinib in Patients with Advanced Hepatocellular Carcinoma: From a Randomized Phase II Study.

  Masatoshi Kudo; Yoon-Koo Kang; Joong-Won Park; Shukui Qin; Yoshitaka Inaba; Eric Assenat; Yoshiko Umeyama; Maria José Lechuga; Olga Valota; Yosuke Fujii; Jean-Francois Martini; J Andrew Williams; Shuntaro Obi

  Liver cancer 7 (2) 148 - 164 2018/05 [Refereed]
  
• Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update.

  Masao Omata; Ann-Lii Cheng; Norihiro Kokudo; Masatoshi Kudo; Jeong Min Lee; Jidong Jia; Ryosuke Tateishi; Kwang-Hyub Han; Yoghesh K Chawla; Shuichiro Shiina; Wasim Jafri; Diana Alcantara Payawal; Takamasa Ohki; Sadahisa Ogasawara; Pei-Jer Chen; Cosmas Rinaldi A Lesmana; Laurentius A Lesmana; Rino A Gani; Shuntaro Obi; A Kadir Dokmeci; Shiv Kumar Sarin

  Hepatology international 11 (4) 317 - 370 2017/07 [Refereed]
  
• Ramucirumab as second-line treatment in patients with advanced hepatocellular carcinoma: Japanese subgroup analysis of the REACH trial.

  Masatoshi Kudo; Etsuro Hatano; Shinichi Ohkawa; Hirofumi Fujii; Akihide Masumoto; Junji Furuse; Yoshiyuki Wada; Hiroshi Ishii; Shuntaro Obi; Shuichi Kaneko; Seiji Kawazoe; Osamu Yokosuka; Masafumi Ikeda; Katsuaki Ukai; Sojiro Morita; Akihito Tsuji; Toshihiro Kudo; Mitsuo Shimada; Yukio Osaki; Ryosuke Tateishi; Gen Sugiyama; Paolo Benjamin Abada; Ling Yang; Takuji Okusaka; Andrew Xiuxuan Zhu

  Journal of gastroenterology 52 (4) 494 - 503 2017/04 [Refereed]
  
• A simple home-based self-monitoring tool for early detection of hand-foot syndrome in cancer patients.

  Naoko Mikoshiba; Noriko Yamamoto-Mitani; Takamasa Ohki; Yoshinari Asaoka; Hironori Yamaguchi; Shuntaro Obi; Kazuki Sato; Kazuhiko Koike; Mitsunori Miyashita

  Japanese journal of clinical oncology 46 (11) 979 - 985 2016/11 [Refereed]
  
• Emergency endoscopic variceal ligation following variceal rupture in patients with advanced hepatocellular carcinoma and portal vein tumor thrombosis: a retrospective study.

  Toshihiro Kawai; Yoko Yashima; Takafumi Sugimoto; Takahisa Sato; Miho Kanda; Nobuyuki Enomoto; Shinpei Sato; Shuntaro Obi

  World journal of surgical oncology 14 52 - 52 2016/02 [Refereed]
  
• Randomized phase II study of axitinib versus placebo plus best supportive care in second-line treatment of advanced hepatocellular carcinoma

  Y. K. Kang; T. Yau; J. W. Park; H. Y. Lim; T. Y. Lee; S. Obi; S. L. Chan; S. K. Qin; R. D. Kim; M. Casey; C. Chen; H. Bhattacharyya; J. A. Williams; O. Valota; D. Chakrabarti; M. Kudo

  Annals of Oncology Oxford University Press 26 (12) 2457 - 2463 1569-8041 2015/12 [Refereed]
  
• Current Status of Hepatic Arterial Infusion Chemotherapy.

  Shuntaro Obi; Shinpei Sato; Toshihiro Kawai

  Liver cancer 4 (3) 188 - 99 2015/09 [Refereed]
  
• Intraarterial 5-fluorouracil and interferon therapy is safe and effective for nonresectable biliary tract adenocarcinoma.

  Yoko Yashima; Shinpei Sato; Toshihiro Kawai; Takafumi Sugimoto; Takahisa Sato; Miho Kanda; Shuntaro Obi

  Hepatology international 9 (1) 142 - 8 2015/01 [Refereed]
  
• Endoscopic submucosal dissection to treat ileal high-grade dysplasia after ileoanal anastomosis for familial adenomatous polyposis: report of a case.

  Takafumi Sugimoto; Takuya Yoichi; Kensuke Suzuki; Toshihiro Kawai; Yoko Yashima; Shinpei Sato; Jun Kawamoto; Shuntaro Obi

  Clinical journal of gastroenterology 7 (6) 481 - 3 2014/12 [Refereed]
  
• The prevalence of small intestinal polyps in patients with familial adenomatous polyposis: a prospective capsule endoscopy study.

  Atsuo Yamada; Hirotsugu Watabe; Takeo Iwama; Shuntaro Obi; Masao Omata; Kazuhiko Koike

  Familial cancer 13 (1) 23 - 8 2014/03 [Refereed]
  
• Serum glycan as a prognostic marker in patients with advanced hepatocellular carcinoma treated with sorafenib.

  Koji Miyahara; Kazuhiro Nouso; Yasuhiro Miyake; Shinichiro Nakamura; Shuntaro Obi; Maho Amano; Kazuko Hirose; Shin-Ichiro Nishimura; Kazuhide Yamamoto

  Hepatology (Baltimore, Md.) 59 (1) 355 - 6 2014/01 [Refereed]
  
• An open-label phase I/II study of tamibarotene in patients with advanced hepatocellular carcinoma.

  Fumihiko Kanai; Shuntaro Obi; Shigetoshi Fujiyama; Shuichiro Shiina; Hideyuki Tamai; Hitoshi Mochizuki; Yukihiro Koike; Jun Imamura; Takayoshi Yamaguchi; Isamu Saida; Osamu Yokosuka; Masao Omata

  Hepatology international 8 (1) 94 - 103 2014/01 [Refereed]
  
• MicroRNA-140 acts as a liver tumor suppressor by controlling NF-κB activity by directly targeting DNA methyltransferase 1 (Dnmt1) expression.

  Akemi Takata; Motoyuki Otsuka; Takeshi Yoshikawa; Takahiro Kishikawa; Yohko Hikiba; Shuntaro Obi; Tadashi Goto; Young Jun Kang; Shin Maeda; Haruhiko Yoshida; Masao Omata; Hiroshi Asahara; Kazuhiko Koike

  Hepatology (Baltimore, Md.) 57 (1) 162 - 70 2013/01 [Refereed]
  
• Systemic combination therapy of intravenous continuous 5-fluorouracil and subcutaneous pegylated interferon alfa-2a for advanced hepatocellular carcinoma.

  Koji Uchino; Shuntaro Obi; Ryosuke Tateishi; Shinpei Sato; Miho Kanda; Takahisa Sato; Toru Arano; Kenichiro Enooku; Eriko Goto; Ryota Masuzaki; Hayato Nakagawa; Yoshinari Asaoka; Yuji Kondo; Noriyo Yamashiki; Tadashi Goto; Shuichiro Shiina; Masao Omata; Haruhiko Yoshida; Kazuhiko Koike

  Journal of gastroenterology 47 (10) 1152 - 9 2012/10 [Refereed]
  
• Percutaneous ethanol injection for hepatocellular carcinoma: 20-year outcome and prognostic factors.

  Shuichiro Shiina; Ryosuke Tateishi; Masatoshi Imamura; Takuma Teratani; Yukihiro Koike; Shinpei Sato; Shuntaro Obi; Fumihiko Kanai; Naoya Kato; Haruhiko Yoshida; Masao Omata; Kazuhiko Koike

  Liver international : official journal of the International Association for the Study of the Liver 32 (9) 1434 - 42 2012/10 [Refereed]
  
• Increased activity of serum mitochondrial isoenzyme of creatine kinase in hepatocellular carcinoma patients predominantly with recurrence.

  Yoko Soroida; Ryunosuke Ohkawa; Hayato Nakagawa; Yumiko Satoh; Haruhiko Yoshida; Hiroto Kinoshita; Ryosuke Tateishi; Ryota Masuzaki; Kenichiro Enooku; Shuichiro Shiina; Takahisa Sato; Shuntaro Obi; Tadashi Hoshino; Ritsuko Nagatomo; Shigeo Okubo; Hiromitsu Yokota; Kazuhiko Koike; Yutaka Yatomi; Hitoshi Ikeda

  Journal of hepatology 57 (2) 330 - 6 2012/08 [Refereed]
  
• Guideline on the use of new anticancer drugs for the treatment of Hepatocellular Carcinoma 2010 update.

  Shuichi Kaneko; Junji Furuse; Masatoshi Kudo; Kenji Ikeda; Masao Honda; Yasunari Nakamoto; Morikazu Onchi; Goshi Shiota; Osamu Yokosuka; Isao Sakaida; Tetsuo Takehara; Yoshiyuki Ueno; Kazumasa Hiroishi; Shuhei Nishiguchi; Hisataka Moriwaki; Kazuhide Yamamoto; Michio Sata; Shuntaro Obi; Shiro Miyayama; Yukinori Imai

  Hepatology research : the official journal of the Japan Society of Hepatology 42 (6) 523 - 42 2012/06 [Refereed]
  
• Safety and tolerance of sorafenib in Japanese patients with advanced hepatocellular carcinoma.

  Sadahisa Ogasawara; Fumihiko Kanai; Shuntaro Obi; Shinpei Sato; Taketo Yamaguchi; Ryosaku Azemoto; Hideaki Mizumoto; Youhei Koushima; Naoki Morimoto; Nobuto Hirata; Takeshi Toriyabe; Yusuke Shinozaki; Yoshihiko Ooka; Rintaro Mikata; Tetsuhiro Chiba; Shinichiro Okabe; Fumio Imazeki; Masaharu Yoshikawa; Osamu Yokosuka

  Hepatology international 5 (3) 850 - 6 2011/09 [Refereed]
  
• Proposed treatment guidance on new anticancer agents for the treatment of hepatocellular carcinoma, 2010 up date : 2010 Health and Labour Sciences Research Grant Research Project on Emergency Measures to Overcome Hepatitis

  KANEKO Shuichi; FURUSE Junji; KUDO Masatoshi; IKEDA Kenji; HONDA Masao; NAKAMOTO Yasunari; ONJI Morikazu; SHIOTA Goshi; YOKOSUKA Osamu; SAKAIDA Isao; TAKEHARA Tetsuo; UENO Yoshiyuki; HIROISHI Kazumasa; NISHIGUCHI Shuhei; MORIWAKI Hisataka; YAMAMOTO Kazuhide; SATA Michio; OBI Shuntaro; MIYAYAMA Shiro; IMAI Yukinori

  Kanzo The Japan Society of Hepatology 52 (8) 532 - 551 0451-4203 2011/08
• Surveillance of small intestinal abnormalities in patients with hepatocellular carcinoma: a prospective capsule endoscopy study.

  Atsuo Yamada; Hirotsugu Watabe; Shuntaro Obi; Takafumi Sugimoto; Shintaro Kondo; Miki Ohta; Goichi Togo; Keiji Ogura; Yutaka Yamaji; Makoto Okamoto; Haruhiko Yoshida; Takao Kawabe; Kazuhiko Koike; Masao Omata

  Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society 23 (2) 124 - 9 2011/04 [Refereed]
  
• A phase I/II trial of the oral antiangiogenic agent TSU-68 in patients with advanced hepatocellular carcinoma.

  Fumihiko Kanai; Haruhiko Yoshida; Ryosuke Tateishi; Shinpei Sato; Takao Kawabe; Shuntaro Obi; Yuji Kondo; Makoto Taniguchi; Kazumi Tagawa; Masafumi Ikeda; Chigusa Morizane; Takuji Okusaka; Hitoshi Arioka; Shuichiro Shiina; Masao Omata

  Cancer chemotherapy and pharmacology 67 (2) 315 - 24 2011/02 [Refereed]
  
• Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma.

  Masao Omata; Laurentius A Lesmana; Ryosuke Tateishi; Pei-Jer Chen; Shi-Ming Lin; Haruhiko Yoshida; Masatoshi Kudo; Jeong Min Lee; Byung Ihn Choi; Ronnie T P Poon; Shuichiro Shiina; Ann Lii Cheng; Ji-Dong Jia; Shuntaro Obi; Kwang Hyub Han; Wasim Jafri; Pierce Chow; Seng Gee Lim; Yogesh K Chawla; Unggul Budihusodo; Rino A Gani; C Rinaldi Lesmana; Terawan Agus Putranto; Yun Fan Liaw; Shiv Kumar Sarin

  Hepatology international 4 (2) 439 - 74 2010/03 [Refereed]
  
• Ultrasound surveillance for early detection of hepatocellular carcinoma among patients with chronic hepatitis C.

  Takahisa Sato; Ryosuke Tateishi; Haruhiko Yoshida; Takamasa Ohki; Ryota Masuzaki; Jun Imamura; Tadashi Goto; Fumihiko Kanai; Shuntaro Obi; Naoya Kato; Shuichiro Shiina; Takao Kawabe; Masao Omata

  Hepatology international 3 (4) 544 - 50 2009/12 [Refereed]
  
• Treatment strategy for hepatocellular carcinoma: expanding the indications for radiofrequency ablation.

  Ryosuke Tateishi; Shuichiro Shiina; Takamasa Ohki; Takahisa Sato; Ryota Masuzaki; Jun Imamura; Eriko Goto; Tadashi Goto; Hideo Yoshida; Shuntaro Obi; Shinpei Sato; Fumihiko Kanai; Haruhiko Yoshida; Masao Omata

  Journal of gastroenterology 44 Suppl 19 142 - 6 2009 [Refereed]
  
• Neoplastic seeding after radiofrequency ablation for hepatocellular carcinoma.

  Jun Imamura; Ryosuke Tateishi; Shuichiro Shiina; Eriko Goto; Takahisa Sato; Takamasa Ohki; Ryota Masuzaki; Tadashi Goto; Hideo Yoshida; Fumihiko Kanai; Keisuke Hamamura; Shuntaro Obi; Haruhiko Yoshida; Masao Omata

  The American journal of gastroenterology 103 (12) 3057 - 62 2008/12 [Refereed]
  
• Extrahepatic metastasis of hepatocellular carcinoma: incidence and risk factors.

  Miho Kanda; Ryosuke Tateishi; Haruhiko Yoshida; Takahisa Sato; Ryota Masuzaki; Takamasa Ohki; Jun Imamura; Tadashi Goto; Hideo Yoshida; Keisuke Hamamura; Shuntaro Obi; Fumihiko Kanai; Shuichiro Shiina; Masao Omata

  Liver international : official journal of the International Association for the Study of the Liver 28 (9) 1256 - 63 2008/11 [Refereed]
  
• Changes in hepatic functional reserve after percutaneous tumor ablation for hepatocellular carcinoma: long-term follow up for 227 consecutive patients with a single lesion.

  Yukihiro Koike; Haruhiko Yoshida; Shuichiro Shiina; Takuma Teratani; Shuntaro Obi; Shinpei Sato; Masatoshi Akamatsu; Ryosuke Tateishi; Tomonori Fujishima; Yujin Hoshida; Miho Kanda; Takashi Ishikawa; Yasushi Shiratori; Masao Omata

  Hepatology international 1 (2) 295 - 301 2007/06 [Refereed]
  
• Obesity did not diminish the efficacy of percutaneous ablation for hepatocellular carcinoma.

  Takamasa Ohki; Ryosuke Tateishi; Shuichiro Shiina; Takahisa Sato; Ryota Masuzaki; Hideo Yoshida; Fumihiko Kanai; Shuntaro Obi; Haruhiko Yoshida; Masao Omata

  Liver international : official journal of the International Association for the Study of the Liver 27 (3) 360 - 7 1478-3223 2007/04 [Refereed]
  
• Prediction of recurrence of hepatocellular carcinoma after curative ablation using three tumor markers.

  Ryosuke Tateishi; Shuichiro Shiina; Haruhiko Yoshida; Takuma Teratani; Shuntaro Obi; Noriyo Yamashiki; Hideo Yoshida; Masatoshi Akamatsu; Takao Kawabe; Masao Omata

  Hepatology (Baltimore, Md.) 44 (6) 1518 - 27 0270-9139 2006/12 [Refereed]
  
• Age-related comparison of the profiles of patients with hepatocellular carcinoma

  Tomonori Fujishima; Takashi Ishikawa; Yasushi Shiratori; Miho Kanda; Ryosuke Tateishi; Masatoshi Akamatsu; Yukihiro Koike; Shinpei Sato; Shuntaro Obi; Keisuke Hamamura; Takuma Teratani; Shuichiro Shiina; Haruhiko Yoshida; Takao Kawabe; Masao Omata

  Hepato-Gastroenterology 53 (72) 913 - 918 0172-6390 2006/11 [Refereed]
  
• Sustained viral response prolonged survival of patients with C-viral hepatocellular carcinoma.

  Masatoshi Akamatsu; Haruhiko Yoshida; Shuichiro Shiina; Takuma Teratani; Shuntaro Obi; Ryousuke Tateishi; Norio Mine; Yuji Kondo; Takao Kawabe; Masao Omata

  Liver international : official journal of the International Association for the Study of the Liver 26 (5) 536 - 42 1478-3223 2006/06 [Refereed]
  
• Absence of PIK3CA hotspot mutations in hepatocellular carcinoma in Japanese patients

  Y. Tanaka; F. Kanai; M. Tada; Y. Asaoka; B. Guleng; A. Jazag; M. Ohta; T. Ikenoue; K. Tateishi; S. Obi; T. Kawabe; O. Yokosuka; M. Omata

  Oncogene 25 (20) 2950 - 2952 0950-9232 2006/05 [Refereed]
  
• Combination therapy of intraarterial 5-fluorouracil and systemic interferon-alpha for advanced hepatocellular carcinoma with portal venous invasion.

  Shuntaro Obi; Haruhiko Yoshida; Risa Toune; Tadao Unuma; Miho Kanda; Shinpei Sato; Ryosuke Tateishi; Takuma Teratani; Shuichiro Shiina; Masao Omata

  Cancer 106 (9) 1990 - 7 0008-543X 2006/05 [Refereed]
  
• Radiofrequency ablation for hepatocellular carcinoma in so-called high-risk locations.

  Takuma Teratani; Haruhiko Yoshida; Shuichiro Shiina; Shuntaro Obi; Shinpei Sato; Ryosuke Tateishi; Norio Mine; Yuji Kondo; Takao Kawabe; Masao Omata

  Hepatology (Baltimore, Md.) 43 (5) 1101 - 8 0270-9139 2006/05 [Refereed]
  
• Absence of PIK3CA hotspot mutations in hepatocellular carcinoma in Japanese patients - The effect of pik3ca pseudogene on mutational analysis

  Yasuo Tanaka; Fumihiko Kanai; Motohisa Tada; Yoshinan Asaoka; Bayasi Guleng; Amarsanaa Jazag; Miki Ohta; Tsuneo Ikenoue; Keisuke Tateishi; Shuntaro Obi; Takao Kawabe; Osamu Yokosuka; Masao Omata

  GASTROENTEROLOGY W B SAUNDERS CO-ELSEVIER INC 130 (4) A832 - A832 0016-5085 2006/04 [Refereed]
  
• NoPIK3CA hotspot mutations in Japanese hepatocellular carcinoma patients

  Yasuo Tanaka; Fumihiko Kanai; Motohisa Tada; Tsuneo Ikenoue; Shuntaro Obi; Shuichiro Shiina

  JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY BLACKWELL PUBLISHING 21 A49 - A49 0815-9319 2006/03 [Refereed]
  
• NoPIK3CA hotspot mutations in Japanese hepatocellular carcinoma patients

  Y. Tanaka; F. Kanai; M. Tada; T. Ikenoue; S. Obi; S. Shiina; T. Kawabe; O. Yokosuka; M. Omata

  PROCEEDINGS OF THE 16TH CONFERENCE OF THE ASIAN PACIFIC ASSOCIATION FOR THE STUDY OF THE LIVER MEDIMOND S R L 19 - + 2006 [Refereed]
  
• Proteomic analysis of sera from hepatocellular carcinoma patients after radiofrequency ablation treatment.

  Takayuki Kawakami; Yujin Hoshida; Fumihiko Kanai; Yasuo Tanaka; Keisuke Tateishi; Tsuneo Ikenoue; Shuntaro Obi; Shinpei Sato; Takuma Teratani; Shuichiro Shiina; Takao Kawabe; Takamasa Suzuki; Naoya Hatano; Hisaaki Taniguchi; Masao Omata

  Proteomics 5 (16) 4287 - 95 1615-9853 2005/11 [Refereed]
  
• A randomized controlled trial of radiofrequency ablation with ethanol injection for small hepatocellular carcinoma.

  Shuichiro Shiina; Takuma Teratani; Shuntaro Obi; Shinpei Sato; Ryosuke Tateishi; Tomonori Fujishima; Takashi Ishikawa; Yukihiro Koike; Haruhiko Yoshida; Takao Kawabe; Masao Omata

  Gastroenterology 129 (1) 122 - 30 0016-5085 2005/07 [Refereed]
  
• Percutaneous radiofrequency ablation for hepatocellular carcinoma. An analysis of 1000 cases.

  Ryosuke Tateishi; Shuichiro Shiina; Takuma Teratani; Shuntaro Obi; Shinpei Sato; Yukihiro Koike; Tomonori Fujishima; Haruhiko Yoshida; Takao Kawabe; Masao Omata

  Cancer 103 (6) 1201 - 9 0008-543X 2005/03 [Refereed]
  
• Factors predisposing to poorly differentiated hepatocellular carcinoma and its recurrence

  M Akamatsu; T Ishikawa; Y Shiratori; Y Koike; SST Teratani; K Hamamura; S Obi; S Sato; RTT Fujishima; Y Imai; H Yoshida; M Omata

  HEPATO-GASTROENTEROLOGY H G E UPDATE MEDICAL PUBLISHING S A 52 (62) 391 - 397 0172-6390 2005/03 [Refereed]
  
• Proposal of a new prognostic model for hepatocellular carcinoma: An analysis of 403 patients

  R. Tateishi; H. Yoshida; S. Shiina; H. Imamura; K. Hasegawa; T. Teratani; S. Obi; S. Sato; Y. Koike; T. Fujishima; M. Makuuchi; M. Omata

  Gut 54 (3) 419 - 425 0017-5749 2005/03 [Refereed]
  
• Analysis of factors influencing hepatocellular carcinoma detection: efficient use of computed tomography during arterial portography and during hepatic arteriography.

  Tomonori Fujishima; Haruhiko Yoshida; Shuntaro Obi; Shuichiro Shiina; Miho Kanda; Ryosuke Tateishi; Masatoshi Akamatsu; Yukihiro Koike; Shinpei Sato; Takuma Teratani; Takao Kawabe; Yasushi Shiratori; Masao Omata

  Journal of gastroenterology 40 (3) 266 - 73 0944-1174 2005/03 [Refereed]
  
• Three-dimensional power doppler ultrasonography for hepatocellular carcinoma: A comparison with angiography?

  Shinpei Sato; Haruhiko Yoshida; Takuma Teratani; Shuntaro Obi; Yukihiro Koike; Shuichiro Shiina; Masao Omata

  Hepato-Gastroenterology 52 (61) 72 - 75 0172-6390 2005/01 [Refereed]
  
• A novel display of reconstruction computed tomography for the detection of small hepatocellular carcinoma.

  Takuma Teratani; Haruhiko Yoshida; Shuichiro Shiina; Shuntaro Obi; Shinpei Sato; Yukihiro Koike; Keisuke Hamamura; Masatoshi Akamatsu; Tomonori Fujishima; Yasuo Imai; Takao Kawabe; Yasushi Shiratori; Masao Omata

  Liver international : official journal of the International Association for the Study of the Liver 24 (6) 619 - 24 1478-3223 2004/12 [Refereed]
  
• Evaluation of transcatheter arterial embolization prior to percutaneous tumor ablation in patients with hepatocellular carcinoma: a randomized controlled trial.

  Masatoshi Akamatsu; Haruhiko Yoshida; Shuntaro Obi; Shinpei Sato; Yukihiro Koike; Tomonori Fujishima; Ryosuke Tateishi; Masatoshi Imamura; Keisuke Hamamura; Takuma Teratani; Shuichiro Shiina; Takashi Ishikawa; Masao Omata

  Liver international : official journal of the International Association for the Study of the Liver 24 (6) 625 - 9 1478-3223 2004/12 [Refereed]
  
• Neither hepatitis C virus genotype nor virus load affects survival of patients with hepatocellular carcinoma.

  Masatoshi Akamatsu; Haruhiko Yoshida; Shuichiro Shiina; Takuma Teratani; Ryosuke Tateishi; Shuntaro Obi; Shinpei Sato; Yukihiro Koike; Tomonori Fujishima; Takashi Ishikawa; Yasushi Shiratori; Masao Omata

  European journal of gastroenterology & hepatology 16 (5) 459 - 66 0954-691X 2004/05 [Refereed]
  
• 肝細胞癌に対する経皮的ラジオ波焼灼療法施行による胆管損傷後に認めた胆管拡張とその対策

  峯 規雄; 建石 良介; 近藤 祐嗣; 山敷 宣代; 藤島 知則; 佐藤 新平; 小尾 俊太朗; 寺谷 卓馬; 伊佐山 浩通; 小松 裕; 椎名 秀一朗; 石川 隆; 吉田 晴彦; 川邉 隆夫; 小俣 政男

  肝臓 (一社)日本肝臓学会 45 (Suppl.1) A176 - A176 0451-4203 2004/04
• Re-appearance of Power Doppler Signals in the Tumor Nodules of Hepatocellular Carcinoma after Transarterial Embolization Reflects Residual Viable Tumor Cells: Histological Confirmation

  Shin'pei Sato; Yasushi Shiratori; Masatoshi Imamura; Shun'taro Obi; Shuichiro Shiina; Masaaki Akahane; Kuni Ohtomo; Masao Omata

  Hepato-Gastroenterology 51 (55) 56 - 61 0172-6390 2004/01 [Refereed]
  
• Clinical Features of Patients with HCC who are Negative for both HBV and HCV Markers

  Hirotsugu Watabe; Yasushi Shiratori; Ryousuke Tateishi; Tomonori Fujishima; Masatoshi Akamatsu; Yukihiro Koike; Shuntaro Obi; Keisuke Hamamura; Shinpei Sato; Takuma Teratani; Shuichiro Shiina; Masao Omata

  Hepato-Gastroenterology 50 (54) 2157 - 2160 0172-6390 2003/11 [Refereed]
  
• Factors Affecting the Prognosis of Patients with Hepatocellular Carcinoma Invading the Portal Vein - A Retrospective Analysis using 952 Consecutive HCC Patients

  Yukihiro Koike; Keiichi Nakagawa; Yasushi Shiratori; Shuichiro Shiina; Masatoshi Imamura; Shinpei Sato; Shuntaro Obi; Takuma Teratani; Keisuke Hamamura; Haruhiko Yoshida; Masao Omata

  Hepato-Gastroenterology 50 (54) 2035 - 2039 0172-6390 2003/11 [Refereed]
  
• Interferon therapy after tumor ablation improves prognosis in patients with hepatocellular carcinoma associated with hepatitis C virus

  Yasushi Shiratori; Shuichiro Shiina; Takuma Teratani; Masatoshi Imamura; Shun'taro Obi; Shin'pei Sato; Yukihiro Koike; Haruhiko Yoshida; Masao Omata

  Annals of Internal Medicine American College of Physicians 138 (4) 299 - 306 0003-4819 2003/02 [Refereed]
  
• Congenital absence of portal vein with multiple hyperplastic nodular lesions in the liver.

  Yasuo Tanaka; Masaki Takayanagi; Yasushi Shiratori; Yasuo Imai; Shuntaro Obi; Ryosuke Tateishi; Miho Kanda; Tomonori Fujishima; Masatoshi Akamatsu; Yukihiro Koike; Keisuke Hamamura; Takuma Teratani; Takashi Ishikawa; Shuichiro Shiina; Masamichi Kojiro; Masao Omata

  Journal of gastroenterology 38 (3) 288 - 94 0944-1174 2003 [Refereed]
  
• Hepatocellular carcinoma in elderly patients: beneficial therapeutic efficacy using percutaneous ethanol injection therapy.

  Takuma Teratani; Takashi Ishikawa; Yasushi Shiratori; Shuichiro Shiina; Haruhiko Yoshida; Masatoshi Imamura; Shuntaro Obi; Shinpei Sato; Keisuke Hamamura; Masao Omata

  Cancer 95 (4) 816 - 23 0008-543X 2002/08 [Refereed]
  
• False positive uptake of metaiodobenzylguanidine in hepatocellular carcinoma

  Y. Inoue; M. Akahane; T. Kitazawa; H. Ijichi; S. Obi; K. Yoshikawa; K. Ohtomo; M. Omata

  British Journal of Radiology British Institute of Radiology 75 (894) 548 - 551 0007-1285 2002 [Refereed]
  
• Hepatic volumetry to predict adverse events in percutaneous ablation of hepatocellular carcinoma

  Yujin Hoshida; Yasushi Shiratori; Yukihiro Koike; Shuntaro Obi; Keisuke Hamamura; Takuma Teratani; Shuichiro Shiina; Masao Omata

  Hepato-Gastroenterology 49 (44) 451 - 455 0172-6390 2002 [Refereed]
  
• Nonsurgical treatment of hepatocellular carcinoma: from percutaneous ethanol injection therapy and percutaneous microwave coagulation therapy to radiofrequency ablation.

  Shuichiro Shiina; Takuma Teratani; Shuntaro Obi; Keisuke Hamamura; Yukihiro Koike; Masao Omata

  Oncology 62 Suppl 1 64 - 8 0030-2414 2002 [Refereed]
  
• Des-γ-carboxy prothrombin as a useful predisposing factor for the development of portal venous invasion in patients with hepatocellular carcinoma: A prospective analysis of 227 patients

  Yukihiro Koike; Yasushi Shiratori; Shinpei Sato; Shuntaro Obi; Takuma Teratani; Masatoshi Imamura; Haruhiko Yoshida; Shuichiro Shiina; Masao Omata

  Cancer 91 (3) 561 - 569 0008-543X 2001/02 [Refereed]
  
• Power doppler signals after percutaneous ethanol injection therapy for hepatocellular carcinoma predict local recurrence of tumors: A prospective study using 199 consecutive patients

  Shin'pei Sato; Yasushi Shiratori; Masatoshi Imamura; Takuma Teratani; Shun'taro Obi; Yukihiro Koike; Yasuo Imai; Haruhiko Yoshida; Shuichiro Shiina; Masao Omata

  Journal of Hepatology 35 (2) 225 - 234 0168-8278 2001 [Refereed]
  
• Hepatocellular carcinoma depicted as hypoattenuation on CT hepatic arteriography (CTA) and hyperattenuation on CT during arterial portography (CTAP)

  Kenji Hirano; Yuji Kondo; Takuma Teratani; Shuntaro Obi; Tomonori Fujishima; Yujin Hoshida; Ryosuke Tateishi; Shinpei Sato; Yukihiro Koike; Shuichiro Shiina; Yasuo Imai; Yasushi Shiratori; Masao Omata

  Journal of Gastroenterology 36 (5) 346 - 349 0944-1174 2001 [Refereed]
  
• Thoracoscopic thermal ablation therapy for hepatocellular carcinoma located beneath the diaphragm

  T. Ishikawa; T. Kohno; T. Shibayama; Y. Fukushima; S. Obi; T. Teratani; S. Shiina; Y. Shiratori; M. Omata

  Endoscopy 33 (8) 697 - 702 0013-726X 2001 [Refereed]
  
• Unique clinical characteristics of patients with hepatocellular carcinoma who present with high plasma des-γ-carboxy prothrombin and low serum α-fetoprotein

  Keisuke Hamamura; Yasushi Shiratori; Shuichiro Shiina; Masatoshi Imamura; Shuntaro Obi; Shinpei Sato; Haruhiko Yoshida; Masao Omata

  Cancer 88 (7) 1557 - 1564 0008-543X 2000/04 [Refereed]
  
• Early detection of haemobilia associated with percutaneous ethanol injection for hepatocellular carcinoma

  Shuntaro Obi; Yasushi Shiratori; Shuichiro Shiina; Keisuke Hamamura; Naoya Kato; Masatoshi Imamura; Takuma Teratani; Shinpei Sato; Yutaka Komatsu; Takao Kawabe; Masao Omata

  European Journal of Gastroenterology and Hepatology Lippincott Williams and Wilkins 12 (3) 285 - 290 0954-691X 2000 [Refereed]
  
• Percutaneous radiofrequency ablation for hepatocellular carcinoma by a cool-tip electrode

  Shuichiro Shiina; Takuma Teratani; Shuntaro Obi; Shinpei Sato; Yukihiro Koike; Takayuki Dan; Masatoshi Akamatsu; Tomonori Fujishima; Naoya Kato; Yasuo Imai; Masatoshi Imamura; Keisuke Hamamura; Yasushi Shiratori; Masao Omata

  Acta Hepatologica Japonica Japan Society of Hepatology 41 (1) 24 - 30 0451-4203 2000 [Refereed]
  
• Risk factors for recurring hepatocellular carcinoma differ according to infected hepatitis virus - An analysis of 236 consecutive patients with a single lesion

  Yukihiro Koike; Yasushi Shiratori; Shinpei Sato; Shuntaro Obi; Takuma Teratani; Masatoshi Imamura; Keisuke Hamamura; Yasuo Imai; Haruhiko Yoshida; Shuichiro Shiina; Masao Omata

  Hepatology W.B. Saunders 32 (6) 1216 - 1223 0270-9139 2000 [Refereed]
  
• Endoscopic variceal ligation is a sufficient procedure for the treatment of oesophageal varices in patients with hepatitis C liver cirrhosis: Comparison with injection sclerotherapy

  Yasuo Hata; Eiji Hamada; Morio Takahashi; Shinichi Ota; Keiji Ogura; Shuichiro Shiina; Makoto Okamoto; Tsuyoshi Okudaira; Takuma Teratani; Shin Maeda; Yukihiro Koike; Shinpei Sato; Shuntaro Obi; Torao Tanaka; Takao Kawabe; Yasushi Shiratori; Tateo Kawase; Masuyo Nomura; Masao Omata

  Journal of Gastroenterology and Hepatology (Australia) Blackwell Publishing 14 (3) 236 - 240 0815-9319 1999 [Refereed]
  
• Power Doppler sonography for hepatocellular carcinoma: Factors affecting the power Doppler signals of the tumors

  Masatoshi Imamura; Yasushi Shiratori; Shuichiro Shiina; Sin'pei Sato; Shun'taro Obi; Takehito Okudaira; Takuma Teratani; Naoya Kato; Masaaki Akahane; Kuni Ohtomo; Manabu Minami; Masao Omata

  Liver 18 (6) 427 - 433 0106-9543 1998/12 [Refereed]
  
• Percutaneous hepatic infarction therapy for hepatocellular carcinoma

  Masatoshi Imamura; Yasushi Shiratori; Shin'pei Sato; Shun'taro Obi; Takehito Okudaira; Takuma Teratani; Naoya Kato; Shuichiro Shiina; Masao Omata

  American Journal of Roentgenology American Roentgen Ray Society 171 (4) 1031 - 1035 0361-803X 1998 [Refereed]
  
• Percutaneous microwave coagulation therapy for liver tumors

  Shiina Shuichiro; Imamura Masatoshi; Obi Shuntaro; Teratani Takuma; Sato Shinpei; Hamamura Keisuke; Kato Naoya; Payawal Diana A; Shiratori Yasushi; Omata Masao

  Journal of Microwave Surgery Study Group of Microwave Surgery 15 65 - 69 0917-7728 1997
• Percutaneous ethanol injection therapy for small, hepatocellular carcinoma

  S. Shiina; M. Imamura; S. Obi; T. Teratani; F. Kanai; N. Kato; Y. Niwa; T. Okudaira; D. A. Payawal; R. Tateishi; Y. Shiratori; M. Omata

  Japanese Journal of Cancer and Chemotherapy 23 (7) 835 - 839 0385-0684 1996 [Refereed]
  

MISC

• 肝細胞癌に対するアテゾリズマブ・ベバシズマブ併用療法の現状:多施設共同研究

  竹内研人; 松本光太郎; 高橋健太郎; 徳冨遥; 高村尚樹; 田村大和; 松本康佑; 三浦亮; 佐藤隆久; 淺岡良成; 佐藤新平; 菊池健太郎; 小尾俊太郎; 田中篤  日本消化器病学会雑誌(Web)  119-  2022
• Sorafenib versus hepatic arterial infusion chemotherapy in patients with advanced hepatocellular carcinoma: A Japanese multi-center large cohort study.

  Sadahisa Ogasawara; Kazuomi Ueshima; Masafumi Ikeda; Yutaka Yasui; Takeshi Terashima; Tatsuya Yamashita; Shuntaro Obi; Shinpei Sato; Hiroshi Aikata; Takumi Ohmura; Hidekatsu Kuroda; Takamasa Ohki; Kengo Nagashima; Masayuki Kurosaki; Kazuaki Chayama; Shuichi Kaneko; Namiki Izumi; Naoya Kato; Masatoshi Kudo; Masao Omata  JOURNAL OF CLINICAL ONCOLOGY  37-  (4)  2019/02
• 肝動注化学療法が奏効した下大静脈浸潤および肝外転移を伴うChild-Pugh分類B、肝細胞癌の1例

  梶山 祐介; 菊池 健太郎; 小尾 俊太郎; 宮川 浩; 佐藤 新平; 安田 一朗  癌と化学療法  45-  (9)  1339  -1341  2018/09
• Regional differences in efficacy/safety/biomarkers in a randomised study of axitinib in 2nd line patients (pts) with advanced hepatocellular carcinoma (HCC).

  Masatoshi Kudo; Joong-Won Park; Shuntaro Obi; Shukui Qin; Eric Assenat; Yoshiko Umeyama; Debasis Chakrabarti; Olga Valota; Yosuke Fujii; Jean-Francois Martini; James Andrew Williams; Yoon-Koo Kang  JOURNAL OF CLINICAL ONCOLOGY  34-  (4)  2016/02
• PROSPECTIVE RANDOMIZED CONTROLLED PHASE III TRIAL COMPARING THE EFFICACY OF SORAFENIB VERSUS SORAFENIB IN COMBINATION WITH LOW-DOSE CISPLATIN/FLUOROURACIL HEPATIC ARTERIAL INFUSION CHEMOTHERAPY IN PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA

  M. Kudo; K. Ueshima; O. Yokosuka; S. Obi; N. Izumi; H. Aikata; H. Nagano; E. Hatano; Y. Sasaki; K. Hino; T. Kumada; K. Yamamoto; Y. Imai; S. Iwadou; C. Ogawa; T. Okusaka; Y. Arai; F. Kanai; K. Akazawa  JOURNAL OF HEPATOLOGY  64-  S209  -S210  2016
• Ramucirumab (RAM) as second-line treatment in patients (pts) with advanced hepatocellular carcinoma (HCC): Japanese subgroup analysis of the phase III REACH trial

  Shinichi Ohkawa; Takuji Okusaka; Masatoshi Kudo; Etsuro Hatano; Hirofumi Fujii; Akihide Masumoto; Junji Furuse; Yoshiyuki Wada; Hiroshi Ishii; Shuntaro Obi; Kuniaki Arai; Seiji Kawazoe; Osamu Yokosuka; Masafumi Ikeda; Katsuaki Ukai; Sojiro Morita; Hiroya Asou; Paolo B. Abada; Ling Yang; Andrew X. Zhu  ANNALS OF ONCOLOGY  26-  94  -94  2015/11
• Prediction of Survival in Patients with Hepatocellular Carcinoma Treated with Sorafenib by Comprehensive Serum Glycan Analysis

  Kazuhiro Nouso; Koji Miyahara; Yuuki Morimoto; Yasuto Takeuchi; Hiroaki Hagihara; Kenji Kuwaki; Hideki Onishi; Fusao Ikeda; Yasuhiro Miyake; Shinichiro Nakamura; Hidenori Shiraha; Akinobu Takaki; Koichi Takaguchi; Takahisa Sato; Shinpei Sato; Shuntaro Obi; Kazuko Hirose; Maho Amano; Shin-Ichiro Nishimura; Kazuhide Yamamoto  HEPATOLOGY  58-  1242A  -1242A  2013/10
• Sorafenib for advanced hepatocellular carcinoma: Comparison with systemic combination therapy of intravenous continuous 5-fluorouracil and pegylated interferon as a historical control

  Koji Uchino; Shuntaro Obi; Yoshinari Asaoka; Ryosuke Tateishi; Shinpei Sato; Miho Kanda; Takahisa Sato; Kenichiro Enooku; Yuji Kondo; Noriyo Yamashiki; Tadashi Goto; Shuichiro Shiina; Haruhiko Yoshida; Kazuhiko Koike  HEPATOLOGY  56-  461A  -461A  2012/10  [Refereed]
  
• 座談会 正念場を迎えた肝癌撲滅戦略 (特集 肝癌撲滅最前線)

  小俣 政男; 椎名 秀一朗; 小尾 俊太郎  内科  104-  (4)  717  -728  2009/10
• 肝性昏睡 (特集 Emergency実践ガイド) -- (疾患と対応 消化器)

  小尾 俊太郎; 佐藤 新平  内科  103-  (6)  1294  -1298  2009/06
• Treatment Response Evaluated By Des-Gamma-Carboxy Prothrombin and Alpha-Fetoprotein L3 Fraction Can Predict Prognosis of Hepatocellular Carcinoma Independently of Radiological Evaluation

  Jun Imamura; Ryosuke Tateishi; Shuntaro Obi; Shuichiro Shiina; Shinpei Sato; Takamasa Ohki; Ryoto Masuzaki; Tadashi Goto; Eriko Goto; Takahisa Sato; Kenichiro Enooku; Haruhiko Yoshida; Takao Kawabe; Masao Omata  GASTROENTEROLOGY  136-  (5)  A862  -A862  2009/05
• Radiofrequency Ablation (RFA) in the Treatment of Hepatocellular Carcinoma (HCC): Long-Term Results

  Shuichiro Shiina; Ryosuke Tateishi; Kenichiro Enooku; Eriko Goto; Takahisa Sato; Takamasa Ohki; Ryota Masuzaki; Jun Imamura; Tadashi Goto; Shuntaro Obi; Haruhiko Yoshida; Takao Kawabe; Masao Omata  GASTROENTEROLOGY  136-  (5)  A858  -A858  2009/05
• Radiofrequency ablation (RFA) in the treatment of hepatocellular carcinoma (HCC)

  Shuichiro Shiina; Ryosuke Tateishi; Eriko Goto; Takahisa Sato; Takamasa Ohki; Ryota Masuzaki; Tadashi Goto; Hideo Yoshida; Fumihiko Kanai; Keisuke Hamamura; Jun Imamura; Shuntaro Obi; Haruhiko Yoshida; Takao Kawabe; Masao Omata  GASTROENTEROLOGY  134-  (4)  A823  -A823  2008/04
• Treatment Strategy of Hepatocellular Carcinoma

  TATEISHI Ryosuke; SHIINA Shuichiro; OHKI Takamasa; SATO Takahisa; MASUZAKI Ryota; IMAMURA Jun; GOTO Tadashi; YOSHIDA Hideo; OBI Shuntaro; HAMAMURA Keisuke; YOSHIDA Haruhiko; OMATA Masao  日本消化器病學會雜誌 = The Japanese journal of gastro-enterology  105-  A35  2008/03
• Impact of hepatitis B core antibody positivity on chronic hepatitis C patients

  Takamasa Ohki; Ryosuke Tateishi; Shuichiro Shiina; Takahisa Sato; Ryota Masuzaki; Tadashi Goto; Hideo Yoshida; Shuntaro Obi; Fumihiko Kanai; Haruhiko Kobashi; Masao Omata  HEPATOLOGY  46-  (4)  627A  -627A  2007/10
• Treatment of recurrent hepatocellular carcinoma after curative radiofrequency ablation

  Ryosuke Tateishi; Shuichiro Shiina; Takamasa Ohki; Takahisa Sato; Ryota Masuzaki; Jun Imamaura; Noriyo Yamashiki; Tadashi Goto; Hideo Yoshida; Shuntaro Obi; Haruhiko Kobashi; Masao Omata  HEPATOLOGY  46-  (4)  422A  -422A  2007/10
• Prediction of recurrence of hepatocellular carcinoma after curative ablation by three tumor markers

  Ryosuke Tateishi; Shuichiro Shiina; Haruhiko Yoshida; Takuma Teratani; Shuntaro Obi; Noriyo Yamashiki; Hideo Yoshida; Masatoshi Akamatsu; Takao Kawabe; Masao Omata  HEPATOLOGY  44-  (4)  503A  -503A  2006/10
• Obesity is an independent risk factor of hepatocarcinogenesis in chronic hepatitis C patients

  Takamasa Ohki; Ryosuke Tateishi; Hayato Nakagawa; Takahisa Sato; Ryota Masuzaki; Yuji Kondo; Jun Imamura; Norio Mine; Tomonori Fujishima; Noriyo Yamashiki; Hideo Yoshida; Masatoshi Akamatsu; Shinpei Sato; Yukihiro Koike; Shuntaro Obi; Takuma Teratani; Naoya Kato; Haruhiko Yoshida; Shuichiro Shiina; Takao Kawabe; Masao Omata  HEPATOLOGY  44-  (4)  495A  -495A  2006/10
• New feasibility study design with hepatocellular carcinoma: A phase I/II study of TSU-68, an oral angiogenesis inhibitor.

  F. Kanai; H. Yoshida; T. Teratani; S. Sato; R. Tateishi; S. Obi; M. Yamashita; T. Kawabe; S. Shiina; M. Omata  JOURNAL OF CLINICAL ONCOLOGY  24-  (18)  213S  -213S  2006/06
• Absence of PIK3CA hotspot mutations in hepatocellular carcinoma in Japanese patients

  Tanaka Yasuo; Kanai Fumihiko; Tada Motohisa; Asaoka Yoshinari; Guleng Bayasi; Jazag Amarsanaa; Ohta Miki; Ikenoue Tsuneo; Tateishi Keisuke; Obi Shuntaro; Kawabe Takao; Yokosuka Osamu; Omata Masao  CANCER RESEARCH  66-  (8)  2006/04  [Refereed]
  
• Forefront of radiofrequency ablation treatment of hepatic cancer. 4. Therapeutic effect and long-term prognosis.

  SHIINA S; Teratani T; Tateishi R; Kondo Y; Yamashiki N; Mine N; Masuzaki R; Yanase M; Obi S; Yoshida H; Kawabe T; Omata M  Kanzo  46-  (4)  179  -184  2005/04
• Radiofrequency ablation for hepatocellular carcinoma: a long-term results

  S Shina; T Teratani; R Tateishi; T Fujishima; Y Kondo; N Yamashiki; N Mine; R Masuzaki; M Yanase; T Ishikawa; S Obi; H Yoshida; T Kawabe; M Omata  GASTROENTEROLOGY  128-  (4)  A761  -A762  2005/04
• Usefulness of transient elastography apparatus for assessing progression of chronic liver disease.

  R Masuzaki; R Tateishi; H Yoshida; Y Kondo; N Mine; N Yamashiki; T Teratani; S Obi; S Shiina; N Kato; F Kanai; T Kawabe; M Omata; M Omata; M Omata  GASTROENTEROLOGY  128-  (4)  A335  -A335  2005/04
• Bile duct injury after radiofrequency ablation of liver tumors

  N Mine; R Tateishi; M Akahane; Y Kondo; N Yamashiki; T Fujishima; S Sato; S Obi; T Teratani; H Isayama; Y Komatsu; M Tada; S Shiina; H Yoshida; T Kawabe; M Omata  GASTROENTEROLOGY  128-  (4)  A454  -A454  2005/04
• A novel display of reconstruction computed tomography for the detection of small hepatocellular carcinoma (vol 24, pg 619, 2004)

  T Teratani; H Yoshida; S Shiina; S Obi; S Sato; Y Koike; K Hamamura; M Akamatsu; T Fujishima; Y Imai; T Kawabe; Y Shiratori; M Omata  LIVER INTERNATIONAL  25-  (1)  196  -196  2005/02
• Recurrence of hepatocellular carcinoma after curative ablation therapy

  H Yoshida; R Tateishi; S Shiina; T Fujishima; M Akamatsu; S Obi; S Sato; T Teratani; T Kawabe; M Omata  GASTROENTEROLOGY  126-  (4)  A736  -A737  2004/04
• Distinguishing benign and malignant focal liver lesions by Kupffer imaging with sonographic contrast agent, Levovist

  SP Sato; H Yoshida; R Tateishi; T Teratani; T Fijishima; S Obi; M Kanda; Y Kondo; N Yamashiki; T Ishikawa; T Kawabe; S Shiina; M Omata  GASTROENTEROLOGY  126-  (4)  A493  -A493  2004/04
• Prospective evaluation of hepatic small nodules: Radiographic findings and probability of hepatocellular carcinoma

  T Fujishima; H Yoshida; S Obi; S Shiina; N Mine; Y Kondo; N Yamashiki; M Kanda; R Tateishi; S Sato; T Teratani; T Ishikawa; T Kawabe; M Omata  GASTROENTEROLOGY  126-  (4)  A726  -A727  2004/04
• Aggressive local ablation therapy may be effective in retaining tumor stage of hepatocellular carcinoma within Milan criteria

  N Yamashiki; R Tateishi; S Shiina; H Yoshida; T Teratani; T Ishikawa; S Obi; S Sato; T Fujishima; M Kanda; Y Kondo; N Mine; T Kawabe; M Omata  GASTROENTEROLOGY  126-  (4)  A609  -A609  2004/04
• Artificial ascites using a special needle to avoid GI tract perforation in radiofrequency ablation (RFA) for liver tumors

  S Shiina; T Teratani; S Sato; R Tateishi; T Fujishima; T Ishikawa; Y Kondo; N Yamashiki; N Mine; M Kanda; S Obi; M Akamatsu; H Yoshida; Y Koike; M Imamura; K Hamamura; H Yoshida; T Kawabe; M Omata  GASTROENTEROLOGY  126-  (4)  A737  -A737  2004/04
• Radiofrequency ablation (RFA) for elderly patients with hepatocellular carcinoma (HCC)

  T Teratani; S Shiina; S Sato; S Obi; M Akamatsu; T Fujishima; R Tateishi; M Kanda; N Yamashiki; N Mine; Y Kondo; H Yoshida; T Ishikawa; H Yoshida; T Kawabe; M Omata  GASTROENTEROLOGY  126-  (4)  A739  -A739  2004/04
• Combination therapy with IFN-alpha and 5-FU result in complete response in 14 cases out of 64 with advanced hepatocellular carcinoma and portal vein invasion.

  S Obi; S Shiina; T Teratani; S Sato; Y Koike; M Akamatu; T Fujishima; R Tateishi; M Kanda; T Ishikawa; H Yoshida; T Kawabe; M Omata  HEPATOLOGY  38-  (4)  765A  -765A  2003/10
• Radiofrequency ablation (RFA) for hepatocellular carcinoma adjacent to other organs

  T Teratani; S Shiina; S Sato; S Obi; Y Koike; M Akamatsu; T Kinbara; T Fujishima; R Tateishi; M Kanda; T Ishikawa; H Yoshida; T Kawabe; M Omata  GASTROENTEROLOGY  124-  (4)  A698  -A698  2003/04
• Relevance of three tumor markers to prognosis and recurrence risk of hepatocellular carcinoma - An analysis of 407 consecutive cases-

  R Tateishi; S Shiina; H Yoshida; T Teratani; Y Koike; S Obi; K Hamamura; M Akamatsu; S Sato; T Fujishima; T Kinbara; M Kanda; T Ishikawa; T Kawabe; M Omata  GASTROENTEROLOGY  124-  (4)  A772  -A772  2003/04
• Recurrence after radiofrequency ablation for hepatocellular carcinoma

  S Shiina; T Teratani; S Sato; R Tateishi; T Kinbara; M Kanda; T Ishikawa; T Fujishima; M Akamatsu; S Obi; H Yoshida; Y Koike; M Imamura; K Hamarama; H Yoshida; T Kawabe; M Omata  GASTROENTEROLOGY  124-  (4)  A774  -A774  2003/04
• Proposal of a new prognostic model for hepatocellular carcinoma - Tokyo score

  R Tateishi; H Yoshida; S Shiina; H Imamura; K Hasegawa; T Teratani; S Obi; S Sato; Y Koike; K Hamamura; M Akamatsu; T Fujishima; M Kanda; T Kimbara; T Ishikawa; T Kawabe; M Makuuchi; M Omata  GASTROENTEROLOGY  124-  (4)  A708  -A708  2003/04
• Effectiveness of combination therapy with IFN-alpha and 5-Fu in advanced hepatocellular carcinoma with tumor invasion of the portal vein

  S Obi; S Shiina; M Omata  HEPATOLOGY  36-  (4)  698A  -698A  2002/10
• Hepatocellular carcinoma detection and the need for CT during arterial portography and CT hepatic arterilography.

  T Fujishima; H Yoshida; S Obi; S Shiina; M Omata  HEPATOLOGY  36-  (4)  687A  -687A  2002/10
• Not the way in which AFP respond to treatment but the AFP level before treatment that tells more of outcome for a patient with hepatocellular carcinoma.

  K Hamamura; S Shiina; T Teratani; S Obi; S Sato; Y Koike; M Akamatsu; R Tateishi; T Fujishima; M Kanda; H Yoshida  HEPATOLOGY  36-  (4)  700A  -700A  2002/10
• Randomized prospective study of prevention from tumor invasion into portal vein in 120 patients with hepatocellular carcinoma by vitamin K-II administration

  Y Koike; Y Shiratori; S Shiina; T Teratani; S Obi; S Sato; K Hamamura; M Akamatsu; R Tateishi; T Fujishima; H Yoshida; T Ishikawa; T Kawase; M Omata  GASTROENTEROLOGY  122-  (4)  A643  -A643  2002/04
• Recurrence of hepatocellular carcinoma (HCC) after radiofrequency ablation (RFA)

  R Tateishi; S Shiina; T Teratani; K Hamamura; S Obi; S Sato; Y Koike; M Akamatsu; T Fujishima; T Ishikawa; Y Shiratori; M Omata  GASTROENTEROLOGY  122-  (4)  A663  -A663  2002/04
• Simple measure to diagnose liver cirrhosis by Doppler ultrasonography; "A five" signal

  SP Sato; S Shiina; T Teratani; K Hamamura; S Obi; M Akamatsu; R Tateishi; T Fujishima; M Kanda; Y Koike; Y Shiratori; M Omata  GASTROENTEROLOGY  122-  (4)  A353  -A353  2002/04
• Radiofrequency ablation (RFA) for hepatocellular carcinoma adjacent to large vessels

  T Teratani; S Shiina; S Obi; Y Koike; K Hamamura; M Akamatsu; Y Dan; T Fujishima; R Tateishi; W Kanda; T Ishikawa; T Ishikawa; H Yoshida; Y Shiratori; M Omata  GASTROENTEROLOGY  122-  (4)  A661  -A661  2002/04
• Efficacy and safety of percutaneous radiofrequency ablation therapy with intrapleural infusion technique for the patients with hepatocellular carcinoma in the hepatic dome

  T Ishikawa; S Shiina; T Teratani; S Obi; K Hamamura; S Sato; Y Koike; M Akamatsu; T Fujishima; R Tateishi; Y Shiratori; M Omata  GASTROENTEROLOGY  122-  (4)  A661  -A661  2002/04
• Radiofrequency ablation (RFA) for liver tumors: Analysis of 588 cases

  S Shiina; T Teratani; S Obi; K Hamamura; S Sato; Y Koike; M Akamatsu; R Tateishi; T Fujishima; M Kanda; H Kuroda; T Ishikawa; Y Shiratori; M Omata  GASTROENTEROLOGY  122-  (4)  A636  -A636  2002/04
• Hemodynamic study on hepatic small nodules: The mechanism of fatty change in hepatocellular carcinoma

  T Fujishima; S Shiina; T Teratani; K Hamamura; S Obi; S Sato; Y Koike; M Akamatsu; RS Tateishi; M Kanda; H Yoshida; T Ishikawa; Y Shiratori; M Omata  GASTROENTEROLOGY  122-  (4)  A675  -A676  2002/04
• Recurrence of hepatocellular carcinoma in relation to changes in clinical findings, especially tumor marker profiles.

  K Hamamura; Y Dan; T Teratani; S Obi; Y Koike; M Akamatsu; R Tateishi; T Fujishima; S Shiina; Y Shiratori; M Omata  HEPATOLOGY  34-  (4)  672A  -672A  2001/10
• Japanese patients with hepatocellular carcinoma is aging.

  R Tateishi; S Shiina; T Teratani; S Obi; K Hamamura; Y Koike; T Fujishima; M Akamatsu; Y Shiratori; M Omata  HEPATOLOGY  34-  (4)  671A  -671A  2001/10
• Clinical utility of CT arterial portography and CT hepatic arteriography: Indication of this invasive technique.

  T Fujishima; S Obi; M Kanda; R Tateishi; M Akamatsu; Y Koike; S Sato; M Imamura; K Hamamura; T Teratani; T Ishikawa; S Shiina; Y Shiratori; M Omata  HEPATOLOGY  34-  (4)  668A  -668A  2001/10
• 肝癌非外科的治療の展望 (特集 日常診療における肝炎・肝癌の診かた考えかた)

  椎名 秀一朗; 寺谷 卓馬; 小尾 俊太郎  診断と治療  89-  (10)  1832  -1836  2001/10
• Percutaneous ethanol injection therapy for liver tumors

  Shuichiro Shiina; Takuma Teratani; Shuntaro Obi; Keisuke Hamamura; Yukihiro Koike; Masao Omata  European Journal of Ultrasound  13-  (2)  95  -106  2001/06
• Diagnostic value of contrast ultrasonography using pulse inversion harmonic imaging in the evaluation of hepatocellular carcinoma. A comparison with CT during hepatic arteriography.

  R Tateishi; S Shiina; T Teratani; S Obi; Y Koike; T Fujishima; K Hamamura; M Akamatsu; Y Imai; T Ishikawa; Y Shiratori; M Omata  GASTROENTEROLOGY  120-  (5)  A560  -A560  2001/04
• Radiofrequency ablation (RFA) for hepatocellular carcinoma (HCC)

  S Shiina; T Teratani; S Obi; K Hamamura; Y Koike; T Ishikawa; M Akamatsu; T Fujishima; R Tateishi; SK Ono-Nita; Y Shiratori; M Omata  GASTROENTEROLOGY  120-  (5)  A560  -A560  2001/04
• Percutaneous radiofrequency ablation therapy with intrapleural infusion technique for hepatocellular carcinoma in the hepatic dome

  T Ishikawa; S Shiina; T Teratani; Y Koike; S Obi; K Hamamura; M Akamastu; T Fujishima; R Tateishi; H Watabe; Y Shiratori; M Omata  GASTROENTEROLOGY  120-  (5)  A559  -A559  2001/04
• Serial change of histological features after radiofrequency ablation (RFA) for hepatocellular carcinoma (HCC)

  T Teratani; S Shiina; S Obi; K Hamamura; Y Koike; M Akamatsu; T Fujishima; R Tateishi; Y Imai; H Yoshida; Y Shiratori; M Omata  GASTROENTEROLOGY  120-  (5)  A558  -A558  2001/04
• Combined therapy of irradiation and percutaneous tumor ablation for hepatocellular carcinoma with portal venous invasion - A consecutive analysis of 53 patients

  Y Koike; Y Shiratori; S Shiina; S Sato; S Obi; T Teratani; M Imamura; K Hamamura; Y Imai; M Akamatsu; T Ishikawa; M Omata  GASTROENTEROLOGY  120-  (5)  A559  -A560  2001/04
• Histological findings after Percutaneous Radiofrequency Ablation Therapy (RFA) for Hepatocellular Carcinoma (HCC)

  Teratani Takuma; Shiina Shuichiro; Imai Yasuo; Obi Shuntaro; Koike Yukihiro; Hamamura Keisuke Hamamura; Akamatsu Masatoshi; Dan Yoshiyuki; Fujishima Tomonori; Tateishi Rhosuke; Ishikawa Takashi; Shiratori Yasuo; Omata Masao  Journal of Microwave Surgery  19-  43  -46  2001
• A caution to use tumor markers in assessing therapeutic effects of hepatocellular carcinoma.

  K Hamamura; Y Dan; S Shiina; T Teratani; S Obi; Y Koike; H Yoshida; Y Shiratori; M Omata  HEPATOLOGY  32-  (4)  618A  -618A  2000/10
• Hepatic volumetry to predict adverse events in percutaneous ablation of hepatocellular carcinoma.

  Y Hoshida; Y Shiratori; Y Koike; S Obi; K Hamamura; T Teratani; S Shiina; M Omata  HEPATOLOGY  32-  (4)  238A  -238A  2000/10
• Percutaneous ethanol injection therapy (PEIT) for hepatocellular carcinoma (HCC) located in coudate lobe-long term follow up.

  S Obi; S Shiina; Y Shiratori; M Omata  HEPATOLOGY  32-  (4)  618A  -618A  2000/10
• Combination of tumor ablation and interferon (IFN) therapy remarkably improves prognosis and liver function in hepatitis C viral-hepatocellular carcinoma (HCC).

  Y Shiratori; S Shiina; T Teratani; M Imamura; S Obi; S Sato; Y Koike; R Tateishi; H Yoshida; M Omata  HEPATOLOGY  32-  (4)  206A  -206A  2000/10
• Early detection of hemobilia following percutaneous ethanol injection therapy for hepatocellular carcinoma: "Hemobilia sign" of gallbladder.

  S Obi; Y Shiratori; S Shiina; K Hamamura; N Kato; M Imamura; T Teratani; S Sato; Y Komatsu; T Kawada; M Omata  GASTROENTEROLOGY  118-  (4)  A914  -A914  2000/04
• Tumor markers represent clinical profiles of hepatocellular carcinoma (HCC).

  Y Dan; S Shiina; T Teratani; S Obi; S Sato; K Hamamura; Y Koike; Y Shiratori; M Omata  GASTROENTEROLOGY  118-  (4)  A992  -A993  2000/04
• Histological features of hepatocellular carcinoma correlate with local recurrence after percutaneous ethanol injection therapy (PEIT).

  R Tateishi; S Sato; S Shiina; T Teratani; S Obi; Y Koike; T Fujishima; Y Dan; K Hamamura; Y Imai; Y Shiratori; M Omata  GASTROENTEROLOGY  118-  (4)  A1011  -A1011  2000/04
• Hepatic volumetry using computed tomography for planning percutaneous ablation of hepatocellular carcinoma.

  Y Hoshida; Y Shiratori; Y Koike; S Obi; K Hamamura; T Teratani; S Shiina; M Omata  GASTROENTEROLOGY  118-  (4)  A1449  -A1449  2000/04
• Two-mm reconstructed CT as a routine tool for diagnosis of small hepatocellular carcinoma (HCC).

  T Teratani; S Shiina; S Obi; S Sato; Y Koike; K Hamamura; M Akamatsu; Y Dan; TM Fujishima; Y Imai; Y Shiratori; M Omata  GASTROENTEROLOGY  118-  (4)  A994  -A994  2000/04
• A caution to use tumor markers in assessing therapeutic effects of hepatocellulular carcinoma (HCC).

  K Hamamura; S Shiina; T Teratani; S Obi; Y Koike; Y Dan; R Tateishi; H Yoshida; Y Shiratori; M Omata  GASTROENTEROLOGY  118-  (4)  A1445  -A1445  2000/04
• Prospective randomized controlled trial comparing percutaneous radiofrequency ablation and percutaneous ethanol injection therapy for small hepatocellular carcinoma.

  S Shiina; T Teratani; S Obi; K Hamamura; Y Koike; T Fujishima; Y Dan; M Imamura; S Sato; T Ishikawa; Y Shiratori; M Omata  GASTROENTEROLOGY  118-  (4)  A959  -A959  2000/04
• Unique clinical profiles of patients with hepatocellular carcinoma less than 50 yeas old.

  T Teratani; S Shiina; S Obi; S Sato; Y Koike; K Hamamura; M Akamatsu; Y Dan; T Fujishima; Y Imai; Y Shiratori; M Omata  GASTROENTEROLOGY  118-  (4)  A994  -A994  2000/04
• Recurrence of hepatitis C virus-related hepatocellular carcinoma increases with severity of liver fibrosis - A prospective analysis of 221 consecutive patients.

  Y Koike; Y Shiratori; S Shiina; T Teratani; S Obi; K Hamamura; S Sato; Y Dan; M Imamura; Y Imai; H Yoshida; M Omata  GASTROENTEROLOGY  118-  (4)  A991  -A991  2000/04
• Risk factors of esophageal variceal bleeding and preventative effect of endoscopic variceal ligation (EVL) in patients with hepatocellular carcinoma

  M Akanuma; H Yoshida; M Okamoto; K Ogura; S Maeda; J Kato; S Shiina; S Obi; S Sato; T Kawabe; Y Shiratori; M Omata  HEPATOLOGY  30-  (4)  219A  -219A  1999/10
• Percutaneous ethanol injection therapy (PEIT) for elderly patients with hepatocellular carcinoma (HCC).

  T Teratani; S Shiina; M Imamura; S Obi; S Sato; Y Koike; Y Dan; M Akamatsu; K Hamamura; N Kato; Y Shiratori; M Omata  GASTROENTEROLOGY  116-  (4)  A1283  -A1283  1999/04
• PEIT alone vs. combination of PEIT & PMCT in the treatment of hepatocellular carcinoma: A prospective randomized trial

  S Shiina; T Teratani; S Obi; S Sato; Y Koike; Y Dan; H Taniguchi; M Akamatsu; N Kato; H Yoshida; M Imamura; K Hamamura  GASTROENTEROLOGY  116-  (4)  A1275  -A1275  1999/04
• Percutaneous ethanol injection therapy (PEIT) for 653 hepatocellular carcinoma (HCC): Single institute experience in 12 years

  S Shiina; T Teratani; S Obi; S Sato; Y Koike; Y Dan; M Dan; N Kato; M Imamura; K Hamamura; Y Shiratori; M Omata  GASTROENTEROLOGY  116-  (4)  A1275  -A1275  1999/04
• Percutaneous ethanol injection therapy (PEIT) for hepatocellular carcinoma (HCC) located in coudate lobe - Long term follow up-

  S Obi; S Shiina; M Imamura; T Teratani; S Sato; Y Koike; Y Dan; Y Imai; Y Shiratori; M Omata  GASTROENTEROLOGY  116-  (4)  A1256  -A1256  1999/04
• Power doppler signals after percutaneous ethanol injection therapy for hepatocellar carcinoma (HCC) predict local recurrence of the tumors. A prospective study

  SP Sato; S Shiina; T Teratani; S Obi; Y Koike; Y Dan; M Akamatsu; H Taniguchi; Y Imai; H Yoshida; Y Shiratori; M Omata  GASTROENTEROLOGY  116-  (4)  A1271  -A1271  1999/04
• Targeted-therapy for portal venous invasion (PVI) of hepatocellular carcinoma (HCC)

  Y Koike; S Shiina; M Imamura; T Teratani; S Obi; K Hamamura; S Sato; Y Dan; M Akamatsu; Y Imai; N Kato; T Kawabe  GASTROENTEROLOGY  116-  (4)  A1232  -A1232  1999/04
• Significance of L3 fraction of AFP in patients with mild AFP elevation

  Y Dan; K Hamamura; S Shiina; M Imamura; T Teratani; S Obi; S Sato; Y Koike; M Akamatsu; H Yoshida; Y Shiratori; M Omata  GASTROENTEROLOGY  116-  (4)  A1200  -A1200  1999/04
• Positional relationship between the primary lesion of hepatocellular carcinoma and its recurrence

  S Shiina; M Imamura; T Teratani; S Obi; K Hamamura; S Sato; H Yoshida; Y Koike; Y Dan; N Kato; H Yoshida; T Kawabe; Y Shiratori; M Omata  HEPATOLOGY  28-  (4)  249A  -249A  1998/10
• Complete ablation of color Doppler signals to evaluate response to treatment with percutaneous ethanol injection for hepatocellular carcinoma.

  S Sato; S Shiina; M Imamura; T Teratani; S Obi; K Hamamura; H Yosida; Y Koike; Y Dan; T Kawabe; T Okudaira; N Kato; H Yosida; Y Shiratori; M Omata  GASTROENTEROLOGY  114-  (4)  A1334  -A1334  1998/04
• Color Doppler signals after transcatheter arterial embolization (TAE) to evaluate response to treatment for hepatocellular carcinoma (HCC).

  S Sato; S Shiina; M Imamura; T Teratani; S Obi; K Hamamura; H Yoshida; Y Koike; Y Dan; T Okudaira; N Kato; T Kawabe; H Yoshida; Y Shiratori; M Omata  GASTROENTEROLOGY  114-  (4)  A1333  -A1333  1998/04
• Percutaneous infarction therapy (PIT) for hepatocellular carcinoma (HCC)

  M Imamura; S Shiina; T Teratani; S Obi; S Sato; K Kamamura; Y Koike; Y Dan; H Yoshida; T Okudaira; F Kanai; N Kato; H Yoshida; T Kawabe; Y Shiratori; M Omata  GASTROENTEROLOGY  114-  (4)  A1261  -A1261  1998/04
• Early detection of hemobilia following percutaneous ethanol injection therapy for hepatocellular carcinoma: "Hemobilia sign" of gallbladder.

  S Obi; S Shiina; M Imamura; T Teratani; K Hamamura; S Sato; H Yoshida; Y Koike; Y Dan; M Akamatsu; T Goto; G Okudaira; N Kato; Y Niwa; Y Shiratori; M Omata  GASTROENTEROLOGY  114-  (4)  A1314  -A1314  1998/04
• Des-gamma-carboxy prothrombin is the most important predisposing factor of portal vein tumor thrombosis (PVTT) in hepatocellular carcinoma (HCC)

  Y Koike; S Shiina; M Imamura; S Obi; K Hamamura; S Sato; H Yoshida; Y Dan; T Goto; T Okudaira; N Kato; T Kawabe; H Yoshida; Y Shiratori; M Omata  GASTROENTEROLOGY  114-  (4)  A1277  -A1277  1998/04
• Percutaneous ethanol injection therapy for patients with hepatocellular carcinoma (HCC) whose serum total bilirubin levels were 2.0 mg/dl or more.

  S Shiina; M Imamura; T Teratani; S Obi; K Hamamura; S Sato; H Yoshida; Y Koike; Y Dan; N Kato; Y Niwa; T Okudaira; H Yoshida; T Kawabe; Y Shiratori; M Omata  GASTROENTEROLOGY  114-  (4)  A1341  -A1341  1998/04
• To what extent should one try to lower tumor markers in treating hepatocellular carcinoma?

  K Hamamura; S Shiina; M Imamura; T Teratani; S Obi; S Sato; H Yoshida; Y Koike; Y Dan; T Okudaira; N Kato; H Yoshida; T Kawabe; Y Shiratori; M Omata  GASTROENTEROLOGY  114-  (4)  A1251  -A1251  1998/04
• Percutaneous ethanol injection therapy for large hepatocellular carcinoma: A long term result

  S Shiina; M Imamura; T Teratani; S Obi; G Tougou; K Hamamura; S Sato; H Yoshida; N Kato; F Kanai; G Okudaira; DA Payawal; R Tateishi; Y Shiratori; M Omata  GASTROENTEROLOGY  112-  (4)  A1382  -A1382  1997/04
• Color doppler energy ultrasound (CDE-US) examination in hepatocellular carcinoma (HCC)

  M Imamura; S Shiina; T Teratani; S Obi; S Sato; K Hamamura; H Yoshida; G Togo; T Okudaira; F Kanai; N Kato; Y Niwa; H Yoshida; Y Shiratori; M Omata  GASTROENTEROLOGY  112-  (4)  A1289  -A1289  1997/04
• Endoscopic ligation of esophageal varices in patients with hepatocellular carcinoma.

  Y Hata; K Ogura; M Okamoto; M Takahashi; S Shiina; T Goto; S Maeda; S Obi; T Teratani; M Imamura; T Okudaira; T Tanaka; T Kawabe; T Kawase; Y Shiratori; M Omata  GASTROENTEROLOGY  112-  (4)  A1279  -A1279  1997/04
• Percutaneous microwave ablation therapy for hepatocellular carcinoma

  S Shiina; M Imamura; T Teratani; S Obi; G Tougou; K Hamamura; S Sato; H Yoshida; N Kato; F Kanai; G Okudaira; DA Payawal; R Tateishi; Y Shiratori; M Omata  GASTROENTEROLOGY  112-  (4)  A655  -A655  1997/04
• Co-infection of hepatitis B and C viruses plays much less role in development of hepatocellular carcinoma (HCC) than generally claimed in Japan

  Y Shiratori; PY Zhang; E Ohno; D Payawal; S Nitta; T Okudaira; N Kato; T Imamura; T Teratani; S Obi; S Shiina; H Yoshida; M Omata  GASTROENTEROLOGY  110-  (4)  A1324  -A1324  1996/04
• Percutaneous ethanol injection therapy for hepatocellular carcinoma

  S Shiina; M Imamura; T Teratani; S Obi; N Kato; F Kanai; Y Niwa; T Okudaira; T Kawabe; S Ota; Y Shiratori; M Omata  GASTROENTEROLOGY  110-  (4)  A1322  -A1322  1996/04